Polymeric phosphoric acid ester of estradiol.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prasterone | The risk or severity of adverse effects can be increased when Prasterone is combined with Polyestradiol phosphate. |
| Exemestane | The therapeutic efficacy of Exemestane can be decreased when used in combination with Polyestradiol phosphate. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Polyestradiol phosphate. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Polyestradiol phosphate. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Polyestradiol phosphate. |
| Lenalidomide | Polyestradiol phosphate may increase the thrombogenic activities of Lenalidomide. |
| Ospemifene | The risk or severity of adverse effects can be increased when Polyestradiol phosphate is combined with Ospemifene. |
| Ropinirole | Polyestradiol phosphate may increase the excretion rate of Ropinirole which could result in a lower serum level and potentially a reduction in efficacy. |
| Thalidomide | Polyestradiol phosphate may increase the thrombogenic activities of Thalidomide. |
| Cetuximab | Polyestradiol phosphate may increase the thrombogenic activities of Cetuximab. |
| Human immunoglobulin G | Polyestradiol phosphate may increase the thrombogenic activities of Human immunoglobulin G. |
| Omalizumab | Polyestradiol phosphate may increase the thrombogenic activities of Omalizumab. |
| Adalimumab | Polyestradiol phosphate may increase the thrombogenic activities of Adalimumab. |
| Gemtuzumab ozogamicin | Polyestradiol phosphate may increase the thrombogenic activities of Gemtuzumab ozogamicin. |
| Indium In-111 satumomab pendetide | Polyestradiol phosphate may increase the thrombogenic activities of Indium In-111 satumomab pendetide. |
| Infliximab | Polyestradiol phosphate may increase the thrombogenic activities of Infliximab. |
| Trastuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Trastuzumab. |
| Rituximab | Polyestradiol phosphate may increase the thrombogenic activities of Rituximab. |
| Basiliximab | Polyestradiol phosphate may increase the thrombogenic activities of Basiliximab. |
| Muromonab | Polyestradiol phosphate may increase the thrombogenic activities of Muromonab. |
| Digoxin Immune Fab (Ovine) | Polyestradiol phosphate may increase the thrombogenic activities of Digoxin Immune Fab (Ovine). |
| Ibritumomab tiuxetan | Polyestradiol phosphate may increase the thrombogenic activities of Ibritumomab tiuxetan. |
| Tositumomab | Polyestradiol phosphate may increase the thrombogenic activities of Tositumomab. |
| Alemtuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Alemtuzumab. |
| Capromab pendetide | Polyestradiol phosphate may increase the thrombogenic activities of Capromab pendetide. |
| Efalizumab | Polyestradiol phosphate may increase the thrombogenic activities of Efalizumab. |
| Antithymocyte immunoglobulin (rabbit) | Polyestradiol phosphate may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit). |
| Natalizumab | Polyestradiol phosphate may increase the thrombogenic activities of Natalizumab. |
| Palivizumab | Polyestradiol phosphate may increase the thrombogenic activities of Palivizumab. |
| Daclizumab | Polyestradiol phosphate may increase the thrombogenic activities of Daclizumab. |
| Bevacizumab | Polyestradiol phosphate may increase the thrombogenic activities of Bevacizumab. |
| Technetium Tc-99m arcitumomab | Polyestradiol phosphate may increase the thrombogenic activities of Technetium Tc-99m arcitumomab. |
| Eculizumab | Polyestradiol phosphate may increase the thrombogenic activities of Eculizumab. |
| Panitumumab | Polyestradiol phosphate may increase the thrombogenic activities of Panitumumab. |
| Ranibizumab | Polyestradiol phosphate may increase the thrombogenic activities of Ranibizumab. |
| Galiximab | Polyestradiol phosphate may increase the thrombogenic activities of Galiximab. |
| Pexelizumab | Polyestradiol phosphate may increase the thrombogenic activities of Pexelizumab. |
| Afelimomab | Polyestradiol phosphate may increase the thrombogenic activities of Afelimomab. |
| Epratuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Epratuzumab. |
| Bectumomab | Polyestradiol phosphate may increase the thrombogenic activities of Bectumomab. |
| Oregovomab | Polyestradiol phosphate may increase the thrombogenic activities of Oregovomab. |
| IGN311 | Polyestradiol phosphate may increase the thrombogenic activities of IGN311. |
| Adecatumumab | Polyestradiol phosphate may increase the thrombogenic activities of Adecatumumab. |
| Labetuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Labetuzumab. |
| Matuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Matuzumab. |
| Fontolizumab | Polyestradiol phosphate may increase the thrombogenic activities of Fontolizumab. |
| Bavituximab | Polyestradiol phosphate may increase the thrombogenic activities of Bavituximab. |
| CR002 | Polyestradiol phosphate may increase the thrombogenic activities of CR002. |
| Rozrolimupab | Polyestradiol phosphate may increase the thrombogenic activities of Rozrolimupab. |
| Girentuximab | Polyestradiol phosphate may increase the thrombogenic activities of Girentuximab. |
| Obiltoxaximab | Polyestradiol phosphate may increase the thrombogenic activities of Obiltoxaximab. |
| XTL-001 | Polyestradiol phosphate may increase the thrombogenic activities of XTL-001. |
| NAV 1800 | Polyestradiol phosphate may increase the thrombogenic activities of NAV 1800. |
| Briakinumab | Polyestradiol phosphate may increase the thrombogenic activities of Briakinumab. |
| Otelixizumab | Polyestradiol phosphate may increase the thrombogenic activities of Otelixizumab. |
| AMG 108 | Polyestradiol phosphate may increase the thrombogenic activities of AMG 108. |
| Iratumumab | Polyestradiol phosphate may increase the thrombogenic activities of Iratumumab. |
| Enokizumab | Polyestradiol phosphate may increase the thrombogenic activities of Enokizumab. |
| Ramucirumab | Polyestradiol phosphate may increase the thrombogenic activities of Ramucirumab. |
| Farletuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Farletuzumab. |
| Veltuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Veltuzumab. |
| Ustekinumab | Polyestradiol phosphate may increase the thrombogenic activities of Ustekinumab. |
| Trastuzumab emtansine | Polyestradiol phosphate may increase the thrombogenic activities of Trastuzumab emtansine. |
| PRO-542 | Polyestradiol phosphate may increase the thrombogenic activities of PRO-542. |
| TNX-901 | Polyestradiol phosphate may increase the thrombogenic activities of TNX-901. |
| Inotuzumab ozogamicin | Polyestradiol phosphate may increase the thrombogenic activities of Inotuzumab ozogamicin. |
| RI 624 | Polyestradiol phosphate may increase the thrombogenic activities of RI 624. |
| Stamulumab | Polyestradiol phosphate may increase the thrombogenic activities of MYO-029. |
| CT-011 | Polyestradiol phosphate may increase the thrombogenic activities of CT-011. |
| Leronlimab | Polyestradiol phosphate may increase the thrombogenic activities of Leronlimab. |
| Glembatumumab vedotin | Polyestradiol phosphate may increase the thrombogenic activities of Glembatumumab vedotin. |
| Olaratumab | Polyestradiol phosphate may increase the thrombogenic activities of Olaratumab. |
| IPH 2101 | Polyestradiol phosphate may increase the thrombogenic activities of IPH 2101. |
| TB-402 | Polyestradiol phosphate may increase the thrombogenic activities of TB-402. |
| Caplacizumab | Polyestradiol phosphate may increase the thrombogenic activities of Caplacizumab. |
| IMC-1C11 | Polyestradiol phosphate may increase the thrombogenic activities of IMC-1C11. |
| Eldelumab | Polyestradiol phosphate may increase the thrombogenic activities of Eldelumab. |
| Lumiliximab | Polyestradiol phosphate may increase the thrombogenic activities of Lumiliximab. |
| Canakinumab | Polyestradiol phosphate may increase the thrombogenic activities of Canakinumab. |
| Ipilimumab | Polyestradiol phosphate may increase the thrombogenic activities of Ipilimumab. |
| Nimotuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Nimotuzumab. |
| Clenoliximab | Polyestradiol phosphate may increase the thrombogenic activities of Clenoliximab. |
| Tocilizumab | Polyestradiol phosphate may increase the thrombogenic activities of Tocilizumab. |
| BIIB015 | Polyestradiol phosphate may increase the thrombogenic activities of BIIB015. |
| Sonepcizumab | Polyestradiol phosphate may increase the thrombogenic activities of Sonepcizumab. |
| Motavizumab | Polyestradiol phosphate may increase the thrombogenic activities of Motavizumab. |
| Elotuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Elotuzumab. |
| AVE9633 | Polyestradiol phosphate may increase the thrombogenic activities of AVE9633. |
| Carotuximab | Polyestradiol phosphate may increase the thrombogenic activities of Carotuximab. |
| XmAb 2513 | Polyestradiol phosphate may increase the thrombogenic activities of XmAb 2513. |
| Coltuximab ravtansine | Polyestradiol phosphate may increase the thrombogenic activities of Coltuximab ravtansine. |
| Lucatumumab | Polyestradiol phosphate may increase the thrombogenic activities of Lucatumumab. |
| Pertuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Pertuzumab. |
| Siplizumab | Polyestradiol phosphate may increase the thrombogenic activities of Siplizumab. |
| Apolizumab | Polyestradiol phosphate may increase the thrombogenic activities of Apolizumab. |
| Sibrotuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Sibrotuzumab. |
| Bivatuzumab | Polyestradiol phosphate may increase the thrombogenic activities of Bivatuzumab. |
| Lerdelimumab | Polyestradiol phosphate may increase the thrombogenic activities of Lerdelimumab. |
| Lexatumumab | Polyestradiol phosphate may increase the thrombogenic activities of Lexatumumab. |
| Reslizumab | Polyestradiol phosphate may increase the thrombogenic activities of Reslizumab. |